Cargando…
Evaluation of a Novel Renewable Hepatic Cell Model for Prediction of Clinical CYP3A4 Induction Using a Correlation-Based Relative Induction Score Approach
Metabolism enzyme induction-mediated drug-drug interactions need to be carefully characterized in vitro for drug candidates to predict in vivo safety risk and therapeutic efficiency. Currently, both the Food and Drug Administration and European Medicines Agency recommend using primary human hepatocy...
Autores principales: | Zuo, Rongjun, Li, Feng, Parikh, Sweta, Cao, Li, Cooper, Kirsten L., Hong, Yulong, Liu, Jin, Faris, Ronald A., Li, Daochuan, Wang, Hongbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Pharmacology and Experimental Therapeutics
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5267519/ https://www.ncbi.nlm.nih.gov/pubmed/28062541 http://dx.doi.org/10.1124/dmd.116.072124 |
Ejemplares similares
-
Transcriptional Regulation of CYP2B6 Expression by Hepatocyte Nuclear Factor 3β in Human Liver Cells
por: Li, Linhao, et al.
Publicado: (2016) -
Inhibition and induction of CYP enzymes in humans: an update
por: Hakkola, Jukka, et al.
Publicado: (2020) -
Drug-induced CYP induction as therapy for tacrolimus intoxication
por: Hoppe, John M., et al.
Publicado: (2022) -
In vitro metabolism, reaction phenotyping, enzyme kinetics, CYP inhibition and induction potential of ataluren
por: Kong, Ronald, et al.
Publicado: (2020) -
Auto-Induction Effect of Chloroxoquinoline on the Cytochrome P450 Enzymes of Rats Associated with CYP 3A and 1A
por: Li, Xin, et al.
Publicado: (2015)